High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.
about
Hematopoietic stem cell: self-renewal versus differentiationBone marrow cell graft engineering: from bench to bedside.Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model.T cells fail to develop in the human skin-cell explants system; an inconvenient truthCancer stem cells as targets for cancer therapy: selected cancers as examples.Cellular and gene therapy for major histocompatibility complex class II deficiency.Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S.Clinical application of hematopoietic progenitor cell expansion: current status and future prospects.The niche as a target for hematopoietic manipulation and regeneration.Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated miceEnhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1Hematopoietic stem-cell behavior in nonhuman primatesVariable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice.HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size.Hematopoietic stem cells: the paradigmatic tissue-specific stem cell.Adhesion in the stem cell niche: biological roles and regulationThe origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells.Epigenetic regulation of aging stem cells.Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood.Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signalingEx vivo expansion of hematopoietic stem cells.Cryopreserved Ex Vivo-Expanded Allogeneic Myeloid Progenitor Cell Product Protects Neutropenic Mice From a Lethal Fungal Infection.The kinetics of clonal dominance in myeloproliferative disorders.Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.Mesenchymal stem cells acquire characteristics of cells in the periodontal ligament in vitro.The road ended up at stem cells.Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment.
P2860
Q29396498-8BF27F35-7247-4E66-9AD4-B2C251FC8ED5Q30666969-5B719F62-67AD-482C-B220-6C34079FBEC0Q33623571-832184A3-2ADD-4CDC-A7D2-A803F4B247CAQ33824150-C9F3365C-838A-4E78-83FD-5054FEF114DFQ34199130-DD5DD08C-CAEC-4B06-A790-D6873943C5C5Q34320793-7A6D4A3D-3FDB-4D79-AB14-230F741BECAFQ34792542-E8C6CC86-A14E-4D4E-A398-BD7724D93AC5Q35079588-41EBBC6B-8136-4DF1-B92D-1AB36419D3B2Q35570041-72892EE0-552A-4E76-BC2B-D3095E41BAEBQ35750865-E1AA59A5-D42C-4227-A17C-873AF0F17125Q35751096-1C936C80-AE23-42D3-B4B6-B3953F289F64Q35990651-361AE979-19F5-438A-97E3-AF8DE7149B43Q36161297-ED26E0B4-BEFC-4026-B422-49AC7C510DE5Q36326611-241F7459-E48D-4BB3-A4ED-9C04D6A4B1A0Q36403763-C5157D38-AEE8-4E1B-82D3-BEB78888E9D0Q36551160-623B2752-8433-4B7F-925C-80D0EF4807ADQ36683651-03CE2406-5FB1-480C-A31F-2CAE08B284A9Q36951804-5ABA678A-4A7E-453E-BA70-10022CB192F7Q37192338-6535538B-75FB-4989-AB4C-592C693EADD9Q37858414-14FCBD65-313B-46C8-B8D8-CD66F646D1A2Q38097003-FEDD1FF6-1877-4B91-A55C-7E1493C266BDQ38121310-83B0D104-8F8B-4608-AC32-731A93912C7CQ38561480-F05824E6-386F-4F24-AAD1-1B8587C4063DQ41155198-1F0DF560-1946-45ED-B2EF-BB51037C8065Q42742394-F458A200-8A4B-468B-95AE-0C2B1E00A049Q45869288-BBA9F8C3-9891-4688-AEFE-929AAFEBFCC8Q47302681-4DF03D56-10E3-4FCE-86F2-D1990A1FEE90Q48504672-47FE63CF-E7B6-4A89-9867-1FEFD3213890Q52721711-AF0903E7-8350-47DE-8254-51BD94C41132
P2860
High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@en
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@nl
type
label
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@en
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@nl
prefLabel
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@en
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@nl
P2093
P2860
P356
P1476
High doses of purified stem ce ...... yngeneic and allogeneic hosts.
@en
P2093
P2860
P304
P356
10.1172/JCI1681
P407
P577
1998-03-01T00:00:00Z